Introgen Therapeutics Inc. raised $11.5 million Wednesday through the private placement of 2 million common shares. (BioWorld Today)

Introgen Therapeutics Inc. raised $11.5 million Wednesday through the private placement of 2 million common shares. (BioWorld Today)

MedImmune Inc. received long-awaited news late Tuesday afternoon as the FDA approved FluMist, a nasally delivered product that has ridden a rocky road throughout the regulatory review process. (BioWorld Today)

MedImmune Inc. received long-awaited news late Tuesday afternoon as the FDA approved FluMist, a nasally delivered product that has ridden a rocky road throughout the regulatory review process. (BioWorld Today)